載入...
How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events?
Recent claims that pioglitazone prevents macrovascular events are based on a secondary outcome measure. But ignoring the primary outcome is statistically unsound
Na minha lista:
| 主要作者: | |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group Ltd.
2005
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1246089/ https://ncbi.nlm.nih.gov/pubmed/16210286 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|